Dextroamphetamine. Evaluation of psychomimetic properties in man.
D000284:Administration, Oral; D000328:Adult; D002395:Catecholamines; D002490:Central Nervous System / Q000187:drug effects; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced; D003913:Dextroamphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006760:Hospitalization; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010259:Paranoid Disorders / Q000139:chemically induced*; D011567:Psychiatric Department, Hospital; D011600:Psychopharmacology; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D012892:Sleep Deprivation; D019966:Substance-Related Disorders; D013431:Sulfates
D002395:Catecholamines; D013431:Sulfates; D003913:Dextroamphetamine